| Predicate |
Object |
| contentType |
Journal Article |
| endingPage |
535 |
| issn |
1052-1372 |
| issueIdentifier |
9 |
| pageRange |
532-535 |
| publicationName |
P & T : a peer-reviewed journal for formulary management |
| startingPage |
532 |
| bibliographicCitation |
D'Ippolito D, Pisano M. Dupilumab (Dupixent): An Interleukin-4 Receptor Antagonist for Atopic Dermatitis. P T. 2018 Sep;43(9):532–5. PMID: 30186024; PMCID: PMC6110636. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6757f61edc68ae3461081977d298378c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2b90da9e686f19a884818b40f51cf8e8 |
| date |
201809 |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/30186024
https://pubmed.ncbi.nlm.nih.gov/PMC6110636 |
| isPartOf |
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/35544
https://portal.issn.org/resource/ISSN/1052-1372 |
| language |
English |
| source |
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
Dupilumab (Dupixent): An Interleukin-4 Receptor Antagonist for Atopic Dermatitis |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7433
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_69c8365c5e015aa60518d03ac8157056 |